enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   The FDA approval for Zenrelia carries a boxed warning stating that dogs should not be vaccinated at least 28 days before and after treatment with the drug, due to the risk of fatal vaccine-induced ...

3. Cefovecin - Wikipedia

   en.wikipedia.org/wiki/Cefovecin

   It is used to treat skin and soft tissue infections in dogs and cats. [4] The antimicrobial effects last for 14 days following administration. [5] In drug studies, cefovecin administered to dogs was 92.4% effective against skin infections (secondary superficial pyoderma, abscesses, and infected wounds). In cats, it was 96.8% effective against ...

4. Skin conditions in dogs: Symptoms, causes, and how to help - AOL

   www.aol.com/skin-conditions-dogs-symptoms-causes...

   Skin conditions in dogs are very common, so it's important to recognize the symptoms and understand the factors that cause them. Dr. Rebecca MacMillan, a vet with over 15 years of experience, says ...

5. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   [20] [21] IL-31 is a key cytokine at the pruritogenic receptors at neurons near the skin, and also induces peripheral blood mononuclear cells and keratinocytes to release pro-inflammatory cytokines. [16] Suppression of IL-4 and IL-13 causes a decrease of T h 2-cell differentiation, which plays a role in atopic dermatitis. [19]

6. FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch ...

   www.aol.com/news/2013-05-16-fda-approves-apoquel...

   MADISON, N.J.--(BUSINESS WIRE)-- Zoetis, Inc. (NYS: ZTS) , formerly the animal health business unit of Pfizer Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved ...

7. Tigilanol tiglate - Wikipedia

   en.wikipedia.org/wiki/Tigilanol_tiglate

   Tigilanol tiglate (USAN; [1]), sold under the brand name Stelfonta is a medication used to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog's skin (subcutaneous), in particular areas of a dog's leg. [2]